76 Biggest Movers From Friday

Gainers

• Marine Petroleum Trust MARPS shares climbed 35.4% to close at $3.33 on Friday.
• Tricida, Inc. TCDA rose 28.8% to close at $5.63. Tricida yesterday issued a regulatory update on veverimer, the only investigational asset in its pipeline.
• Air Industries Group AIRI rose 27.8% to close at $1.32 after the company Reported Thursday that sales returned to pre-pandemic levels. Air Industries Group posted quarterly sales of $13.66 million.
• Daseke, Inc. DSKE shares rose 26.6% to close at $6.57 after the company reported third-quarter earnings, well ahead of consensus estimates.
• Atea Pharmaceuticals, Inc. AVIR gained 26.4% to close at $30.34 after pricing its IPO at $24 per share.
• Build-A-Bear Workshop, Inc. BBW rose 24.4% to close at $4.13. Build-A-Bear Workshop, last week, issued strong Q3 sales guidance.
• Acadia Healthcare Company, Inc. ACHC surged 23% to close at $35.65 after the company reported better-than-expected Q3 results and issued strong Q4 earnings guidance.
• Novus Therapeutics, Inc. NVUS surged 22.2% to close at $26.18.
• MICT, Inc. MICT shares gained 21.9% to close at $3.12.
• LENSAR, Inc. LNSR surged 19.6% to close at $9.76.
• Covanta Holding Corporation CVA gained 19.2% to close at $9.08 after the company reported better-than-expected Q3 results.
• O2Micro International Limited OIIM rose 18.2% to close at $6.42 after the company reported better-than-expected Q3 results.
• Rogers Corporation ROG climbed 17.7% to close at $121.22 after the company reported better-than-expected Q3 results and issued strong Q4 guidance.
• DASAN Zhone Solutions, Inc. DZSI climbed 17.6% to close at $11.39 after the company reported better-than-expected Q3 results.
• MoneyGram International, Inc. MGI rose 14.7% to close at $5.15 after the company reported better-than-expected Q3 results.
• Goosehead Insurance, Inc GSHD rose 14.5% to close at $122.54 following Q3 results.
• RISE Education Cayman Ltd REDU surged 13.9% to close at $5.73.
• Inventiva S.A. IVA surged 13.7% to close at $12.90. Inventiva, last month, said the FDA has granted fast track designation to odiparcil, its clinical-stage drug candidate for the treatment of mucopolysaccharidoses type VI, a rare and progressive genetic disorder.
• Fisker, Inc. FSR gained 13.2% to close at $10.14 after the completion of a special purpose acquisition company merger with Spartan Energy Acquisition.
• Invacare Corporation IVC surged 12.8% to close at $8.11 after beating quarterly estimates.
• Applied DNA Sciences, Inc. APDN gained 12.5% to close at $7.71. Applied DNA Sciences announced plans to increase COVID-19 Surveillance testing capacity at Applied DNA Clinical Laboratories.
• Ribbon Communications Inc. RBBN gained 11.7% to close at $4.31 after the company reported better-than-expected Q3 results.
• Mohawk Industries, Inc. MHK climbed 10.9% to close at $103.19 after the company reported better-than-expected Q3 results.
• Cross Country Healthcare, Inc. CCRN gained 10.1% to close at $7.85. Cross Country Healthcare is expected to release quarterly earnings on November 4.
• U.S. Xpress Enterprises, Inc. USX shares gained 9.6% to close at $7.21.
• ResMed Inc. RMD rose 6.9% to close at $191.94 after the company reported better-than-expected Q1 results.
• The9 Limited NCTY rose 5.8% to close at $2.19.
• Equillium, Inc. EQ rose 5.8% to close at $6.35 after the company reported it received FDA clearance of COVID-19 IND for Phase 3 trial.
• Newell Brands Inc NWL gained 5% to close at $17.66 after the company reported better-than-expected Q3 results. The company also reinstated guidance.
• Zendesk, Inc. ZEN rose 4.6% to close at $110.94 after the company reported better-than-expected Q3 results and also issued strong sales guidance.
• Alphabet Inc. GOOG rose 3.4% to close at $1,621.01 following upbeat Q3 results.

Check out these big penny stock gainers and losers

Losers

• Axovant Gene Therapies Ltd. AXGT shares dipped 41.6% to close at $2.13 on Friday after the company announced updates to be presented at its virtual Parkinson's disease R&D day, stating individual patient-level data from cohort 2 of the Phase 2 SUNRISE-PD study that is evaluating its AXO-Lenti-PD gene therapy for the treatment of Parkinson's disease showed favorable safety and tolerability profile, with no serious adverse events. The company also said it is unlikely that its planned sham-controlled trial of AXO-Lenti-PD will begin to enroll patients by the end of calendar year 2021.
• Bellicum Pharmaceuticals, Inc. BLCM shares tumbled 37.1% to close at $3.71 on Friday after the company priced its 4.15 million shares at $6.025 per share. Wells Fargo downgraded the stock from Overweight to Equal-Weight and announced a price target of $4.5 per share.
• Pitney Bowes Inc. PBI dropped 28.5% to close at $5.31 after the company reported Q3 earnings results.
• Intec Pharma Ltd. NTEC shares fell 25.6% to close at $2.29. Intec Pharma yesterday announced a 1-for-20 reverse share split.
• Columbia Sportswear Company COLM fell 22.5% to close at $74.59 after the company reported worse-than-expected Q3 results. The company also issued weak Q4 forecast.
• MicroVision, Inc. MVIS fell 21.7% to close at $1.73 after the company reported Q3 earnings results.
• Twitter, Inc. TWTR dipped 21.1% to close at $41.36. Twitter posted upbeat sales for its third quarter, while average daily active users rose just around 1 million from the previous quarter to 187 million last quarter.
• Polar Power, Inc. POLA fell 20.5% to close at $2.94 after gaining over 58% on Thursday.
• El Pollo Loco Holdings, Inc. LOCO fell 19.8% to close at $14.12 following weak quarterly sales.
• Hepion Pharmaceuticals, Inc. HEPA shares declined 19.5% to close at $2.69.
• HighPoint Resources Corporation HPR dropped 17.9% to close at $5.52. HighPoint Resources completed 1-for-50 reverse stock split.
• RAVE Restaurant Group, Inc. RAVE fell 17.3% to close at $0.7196. Rave Restaurant announced the return of its contactless buffet to-go along with 3 new meals.
• SQZ Biotechnologies Co SQZ shares dropped 17.2% to close at $13.25 after the company priced its IPO at $16 per share.
• Jianpu Technology Inc. JT fell 17.1% to close at $3.74.
• Greenland Technologies Holding Corporation GTEC dipped 17% to close at $1.81.
• The Goodyear Tire & Rubber Company GT dropped 16.6% to close at $8.28 despite reporting better-than-expected Q3 results.
• Progenity, Inc. PROG dipped 16.3% to close at $4.99. Progenity, last week, reported successful achievement of its preeclampsia test analytical verification milestone.
• OPKO Health, Inc. OPK fell 16.2% to close at $3.52 after the company reported Q3 earnings results.
• Medalist Diversified REIT, Inc. MDRR dropped 15.7% to close at $1.93.
• HEXO Corp. HEXO shares fell 15.5% to close at $0.6075 after reporting Q4 results. The company reported a proposed 8-for-1 consolidation of common shares. The proposal will be submitted for approval on December 11th.
• Range Resources Corporation RRC dipped 15.2% to close at $6.58 following Q3 earnings.
• Data I/O Corporation DAIO dipped 14.3% to close at $3.41 following wider-than-projected quarterly loss.
• Bloom Energy Corporation BE fell 14.1% to close at $12.64 after the company reported worse-than-expected Q3 sales. Morgan Stanley maintained Bloom Energy with an Overweight and lowered the price target from $23 to $22.
• TuanChe Limited TC dropped 14.1% to close at $3.28.
• U.S. Energy Corp. USEG fell 13.6% to close at $4.02 after announcing a 5.75 million share common stock shelf offering.
• Seagen Inc. SGEN fell 13.3% to close at $166.80 after the company cut FY20 sales guidance
• Cellect Biotechnology Ltd. APOP fell 13% to close at $1.81. Cellect Biotechnology shares jumped 22% on Thursday after the company commenced collaboration with XNK Therapeutics to advance novel NK cell-based therapies.
• Electro-Sensors, Inc. ELSE fell 12.9% to close at $3.51 after gaining 7% on Thursday.
• Unity Software Inc. U fell 12.8% to close at $94.88.
• Performance Shipping Inc PSHG shares fell 12% to close at $0.4311 after the company reported a 1-for-10 reverse stock split.
• Digital Turbine, Inc. APPS fell 10% to close at $28.69 after reporting Q2 results.
• Atlassian Corporation Plc TEAM fell 9.1% to close at $191.62 after the company reported Q1 results and issued weak Q2 EPS and sales guidance.
• The Peck Company Holdings, Inc. PECK fell 8.8% to close at $6.56. The Peck Co, earlier during the month, announced $7.641 million in contracts from a 10.5MW portfolio of solar projects in Vermont..
• Evogene Ltd. EVGN fell 8.4% to close at $2.72 as the company priced $12 million direct offering at $2.50 per share.
• Avis Budget Group, Inc. CAR fell 8.3% to close at $33.67 after reporting a decline in quarterly earnings.
• Medigus ADR MDGS fell 7.6% to close at $2.30 after the company announced Purex will launch a Covid-19 product line on Amazon. Medigus previously signed an agreement to acquire a controlling stake in Purex.
• Aptorum Group Limited APM fell 7.1% to close at $2.10 after gaining over 10% on Thursday.
• Electrameccanica Vehicles Corp. SOLO fell 7% to close at $2.78 after gaining 20% on Thursday. ElectraMeccanica highlighted arrival of first production SOLO electric vehicles and opening of 6 new retail locations.
• Credit Acceptance Corporation CACC fell 6.5% to close at $298.12 after reporting downbeat quarterly sales.
• Facebook, Inc. FB dropped 6.3% to $263.11 after reporting quarterly results.
• Sunworks, Inc. SUNW fell 6.3% to close at $2.82 after climbing over 10% on Thursday.
• Universal Security Instruments, Inc. UUU shares fell 6.1% to close at $3.07. Universal Security Instruments shares surged over 62% on Thursday after the company said it received a letter from 9.9% stakeholder Activist Investing threatening shareholder action to prevent delisting and bankruptcy.
• Marin Software Incorporated MRIN fell 5.7% to close at $2.47. Marin Software, earlier during the week, issued preliminary Q3 financial results.
• ZoomInfo Technologies Inc. ZI fell 5.7% to close at $37.99.
• Apple Inc. AAPL fell 5.6% to close at $108.86. Apple announced better-than-expected results for its fiscal fourth-quarter. Apple's flagship product – the iPhone – fetched revenues of $26.44 billion, down 20.7%.